Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets

被引:1
|
作者
Vergara, Ismael A. [1 ,2 ,3 ]
Aivazian, Karina [1 ,4 ,5 ]
Carlino, Matteo S. [1 ,6 ,7 ]
Guminski, Alexander D. [1 ,8 ,9 ]
Maher, Nigel G. [1 ,2 ,4 ,5 ]
Shannon, Kerwin F. [1 ,2 ,10 ]
Ch'ng, Sydney [1 ,2 ,10 ]
Saw, Robyn P. M. [1 ,2 ,10 ]
Long, Georgina, V [1 ,2 ,3 ,8 ,9 ]
Wilmott, James S. [1 ,2 ,3 ]
Scolyer, Richard A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Univ Sydney, Charles Perkin Ctr, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia
[5] NSW Hlth Pathol, Sydney, NSW, Australia
[6] Blacktown Hosp, Dept Med, Blacktown, NSW, Australia
[7] Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med, Sydney, NSW, Australia
[8] Royal North Shore, Sydney, NSW, Australia
[9] Mater Hosp, Sydney, NSW, Australia
[10] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
basal cell carcinoma; diagnosis; drivers; genomics; metastasis; pathology; therapeutic targets; treatment; COPY NUMBER; TUMOR; CANCER; PATHWAY; MUTATIONS; G691S; PHOSPHORYLATION; POLYMORPHISM; PROGRESSION; ACTIVATION;
D O I
10.1016/j.modpat.2023.100099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Basal cell carcinomas (BCCs) are human beings' most common malignant tumors. Most are easily managed by surgery or topical therapies, and metastasis is rare. Although BCCs can become locally advanced, metastatic BCCs are very uncommon and may be biologically distinct. We assessed the clinicopathologic characteristics of 17 patients with metastatic BCC and pursued whole-exome sequencing of tumor and germline DNA from 8 patients. Genomic profiling revealed aberrant acti-vation of Hedgehog signaling and alterations in GLI transcriptional regulators and Notch and Hippo signaling. Matched local recurrences of primary BCCs and metastases from 3 patients provided evi-dence of a clonal origin in all cases. Mutations associated with YAP inhibition were found exclusively in 2 hematogenously-spread lung metastases, and metastatic BCCs were enriched for mutations in the YAP/TAZ-binding domain of TEAD genes. Accordingly, YAP/TAZ nuclear localization was associated with metastatic types and Hippo mutations, suggesting an enhanced oncogenic role in hematogenously-spread metastases. Mutations in RET, HGF, and phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) signaling were enriched compared with a cohort of low clinical-risk BCCs. Our results implicate Hippo and PI3K/AKT dysregulation in metastatic progression of BCCs, making these potential therapeutic targets in metastatic disease. The common clonal origin of matched recurrent and metastatic BCCs suggests that molecular profiling can assist in determining the nature/origin of poorly differentiated metastatic tumors of uncertain type. Genes and pathways enriched for mutations in this cohort are candidate drivers of metastasis and can be used to identify patients at high risk of metastasis who may benefit from aggressive local treatment and careful clinical follow-up.(c) 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma
    Shi, Dong-Min
    Dong, Shuang-Shuang
    Zhou, Hong-Xing
    Song, Dong-Qiang
    Wan, Jin-Liang
    Wu, Wei-Zhong
    CELLULAR SIGNALLING, 2023, 104
  • [2] Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets
    Lee, Hwajeong
    Wang, Kai
    Johnson, Adrienne
    Jones, David M.
    Ali, Siraj M.
    Elvin, Julia A.
    Yelensky, Roman
    Lipson, Doron
    Miller, Vincent A.
    Stephens, Philip J.
    Javle, Milind
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (05) : 403 - 408
  • [3] Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets
    Ghatalia, Pooja
    Yang, Eddy S.
    Lasseigne, Brittany N.
    Ramaker, Ryne C.
    Cooper, Sara J.
    Chen, Dongquan
    Sudarshan, Sunil
    Wei, Shi
    Guru, Arjun S.
    Zhao, Amy
    Cooper, Tiffiny
    Della Manna, Deborah L.
    Naik, Gurudatta
    Myers, Richard M.
    Sonpavde, Guru
    PLOS ONE, 2016, 11 (08):
  • [4] Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma
    Chao, Angel
    Huang, Chen-Yang
    Yu, Willie
    Lin, Chiao-Yun
    Lin, Hao
    Chao, An-Shine
    Lin, Cheng-Tao
    Chou, Hung-Hsueh
    Huang, Kuang-Gen
    Huang, Huei-Jean
    Chang, Ting-Chang
    Rozen, Steven G.
    Wu, Ren-Chin
    Lai, Chyong-Huey
    BMC CANCER, 2024, 24 (01)
  • [5] Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
    Becerra, Maria F.
    Reznik, Ed
    Redzematovic, Almedina
    Tennenbaum, Daniel M.
    Kashan, Mahyar
    Ghanaat, Mazyar
    Casuscelli, Jozefina
    Manley, Brandon
    Jonsson, Philip
    DiNatale, Renzo G.
    Blum, Kyle A.
    Durack, Jeremy C.
    Solomon, Stephen B.
    Arcila, Maria E.
    Bourque, Caitlin
    Socci, Nick
    Carlo, Maria I.
    Lee, Chung-Han
    Voss, Martin H.
    Feldman, Darren R.
    Motzer, Robert J.
    Coleman, Jonathan A.
    Russo, Paul
    Cheng, Emily H.
    Hakimi, A. Ari
    Hsieh, James J.
    EUROPEAN UROLOGY FOCUS, 2018, 4 (06): : 986 - 994
  • [6] Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
    Cheasley, Dane
    Nigam, Abhimanyu
    Zethoven, Magnus
    Hunter, Sally
    Etemadmoghadam, Dariush
    Semple, Timothy
    Allan, Prue
    Carey, Mark S.
    Fernandez, Marta L.
    Dawson, Amy
    Kobel, Martin
    Huntsman, David G.
    Le Page, Cecile
    Mes-Masson, Anne-Marie
    Provencher, Diane
    Hacker, Neville
    Gao, Yunkai
    Bowtell, David
    deFazio, Anna
    Gorringe, Kylie L.
    Campbell, Ian G.
    JOURNAL OF PATHOLOGY, 2021, 253 (01) : 41 - 54
  • [7] Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
    Morris, Van
    Rao, Xiayu
    Pickering, Curtis
    Foo, Wai Chin
    Rashid, Asif
    Eterovic, Karina
    Kim, Taebeom
    Chen, Ken
    Wang, Jing
    Shaw, Kenna
    Eng, Cathy
    MOLECULAR CANCER RESEARCH, 2017, 15 (11) : 1542 - 1550
  • [8] Neck metastatic basal cell carcinoma, a therapeutic challenge
    Irving Salazar-Jimenez, Marcos
    Angel Monroy-Ramirez, Miguel
    Del Carmen-Ortega, Ignacio
    Herrera-Gonzalez, Antonio
    Alvarado-Duran, Javier
    GACETA MEXICANA DE ONCOLOGIA, 2019, 18 : 42 - 46
  • [9] Metastatic basal cell carcinoma
    Akinci, M.
    Aslan, S.
    Markoc, F.
    Cetin, B.
    Cetin, A.
    ACTA CHIRURGICA BELGICA, 2008, 108 (02) : 269 - 272
  • [10] METASTATIC BASAL-CELL CARCINOMA
    BEAULIEULACOSTE, I
    JOLY, P
    RUTO, F
    THOMINE, E
    FUSADE, T
    CHEVALLIER, B
    ORTOLI, JC
    LAURET, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1993, 120 (02): : 135 - 138